# Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints

> **NCT02571634** · PHASE4 · COMPLETED · sponsor: **Defense and Veterans Center for Integrative Pain Management** · enrollment: 23 (actual)

## Conditions studied

- Minor Procedural Pain

## Interventions

- **DRUG:** Lazanda

## Key facts

- **NCT ID:** NCT02571634
- **Lead sponsor:** Defense and Veterans Center for Integrative Pain Management
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02571634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02571634, "Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02571634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*